针对中国肝脏代谢和慢性炎症疾病的创新药疗法
Feng Zhang1, Jiaming Ju1, Hongtao Diao1
1Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases, the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
British journal of pharmacology
|March 21, 2024
概括
中国面临着由乙型肝炎和脂肪肝驱动的严重肝病负担. 传统中医,细胞和基因疗法的研究进展为治疗提供了新的希望.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 肝病是全球主要的健康问题,在中国面临着独特的挑战.
- 乙型肝炎和非酒精性脂肪肝病是中国肝病的主要原因,导致肝细胞癌的高发病率.
- 尽管新型治疗方法有限,但在肝病管理方面取得了重大进展.
研究的目的:
- 为中国肝病流行病学提供全面的概述.
- 审查中国研究人员在预防,诊断和治疗肝病方面的进展.
- 突出传统中医药和新兴疗法的潜力.
主要方法:
- 对中国肝病的流行病学数据的审查.
- 对治疗肝脏疾病的中国传统医学研究趋势的分析.
- 探索新的治疗策略,包括细胞外囊泡,细胞疗法和基因疗法.
主要成果:
- 中国的肝病发病率很高,具有特定的病因因素和肝细胞癌的显着负担.
- 传统中医药在治疗肝病方面表现出显著的疗效和安全性.
- 关于细胞外囊泡,细胞疗法和基因疗法的新兴研究表明,未来肝脏疾病治疗具有前途.
结论:
- 中国研究人员正在为了解和治疗肝脏疾病做出重大贡献.
- 传统中医提供了一种有价值的治疗途径,副作用最小.
- 像细胞和基因疗法这样的创新方法代表了肝脏疾病管理的未来.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
01:29Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86